Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial
Background Memantine has been used off-label to treat frontotemporal lobar degeneration
(FTD). A previous 26-week open-label study suggested a transient, modest benefit on …
(FTD). A previous 26-week open-label study suggested a transient, modest benefit on …